Your browser doesn't support javascript.
loading
Development of activity standard for 90 Y microspheres.
Mo, L; Avci, B; James, D; Simpson, B; Van Wyngaardt, W M; Cessna, J T; Baldock, C.
Affiliation
  • Mo L; Australian Nuclear Science and Technology Organisation, New Illawarra Road, Lucas Heights, NSW 2234, Australia. Imx@ansto.gov.au
Appl Radiat Isot ; 63(2): 193-9, 2005 Aug.
Article in En | MEDLINE | ID: mdl-15963429
ABSTRACT
(90)Y microspheres are important therapeutic radiopharmaceuticals used in the treatment of liver cancer through a process known as selective internal radiation therapy. SIR-spheres is a radiopharmaceutical product that is comprised of (90)Y microspheres suspended in sterile, pyrogen-free water for injection into patients. It is necessary to establish for the SIR-spheres production the capability of accurately measuring the activity of this product to a traceable national measurement standard. An activity standard for SIR-spheres was developed from a standard for (90)Y solution, employing a highly quantifiable chemical digestion process. Calibration factors for the manufacturer's ionisation chambers were determined for 1 and 5 ml of the SIR-spheres product placed in Wheaton vials, for both 34% and 44% of (90)Y microsphere concentration.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Quality Assurance, Health Care / Radiometry / Yttrium Radioisotopes / Radiopharmaceuticals Type of study: Evaluation_studies / Guideline Country/Region as subject: Oceania Language: En Journal: Appl Radiat Isot Year: 2005 Document type: Article
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Quality Assurance, Health Care / Radiometry / Yttrium Radioisotopes / Radiopharmaceuticals Type of study: Evaluation_studies / Guideline Country/Region as subject: Oceania Language: En Journal: Appl Radiat Isot Year: 2005 Document type: Article